You are here: Industry Insights > Victoza

News List

Which Blood Sugar Meds Work Best Against Type 2 Diabetes? drugs
June 30, 2021
You have type 2 diabetes, and you are already taking an old standby drug, metformin. But you still need help controlling your blood sugar levels.
Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData expresspharma
April 12, 2021
There are diverse development strategies and trends in Parkinson’s disease (PD) treatment at present, however, only a few of them address the pressing need for a disease-modifying therapy (DMT).
Novo Nordisk files lawsuit against Mylan for generic application europeanpharmaceuticalreview
August 27, 2019
The two pharmaceutical companies are facing a legal battle after Mylan filed a new drug application for a generic of Novo Nordisk’s Victoza.
FDA Approves Victoza for Type 2 Diabetes in Children and Adolescents americanpharmaceuticalreview
June 21, 2019
Novo Nordisk announced the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Victoza® (liraglutide) injection to lower blood sugar along with diet and exercise in children and adolescents aged 10-17 years with type 2 diabetes
FDA approves Novo Nordisk’s type 2 diabetes drug Victoza pharmaceutical-technology
June 20, 2019
Novo Nordisk has secured approval for Victoza (liraglutide) from the US Food and Drug Administration (FDA) to treat paediatric patients aged ten years or older with type 2 diabetes.
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes drugs
June 19, 2019
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes.
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes drugs
June 18, 2019
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes.
Novo Nordisk’s Victoza found to cut blood sugar in children pharmatimes
April 29, 2019
The results showed that the safety profile of Victoza seen in children and adolescents was similar to that seen in adults.
Novo Nordisk settles Victoza patent dispute with Teva in US pharmaceutical-technology
March 20, 2019
Available in pre filled pens, Victoza is indicated to improve glycemic control in type 2 diabetes. Credit: Novo Nordisk A/S.
Novo Nordisk launches type II diabetes awareness campaign pharmatimes
November 29, 2018
Novo Nordisk UK is launching a campaign to raise awareness of the risk of heart attacks and strokes in people living with type II diabetes.

Previous page 1 2 Next page